Journal
Blood Advances
Publication Date
8-13-2024
Volume
8
Issue
15
First Page
4035
Last Page
4049
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2022007792
Rights and Permissions
Ramirez CA, Becker-Hapak M, Singhal K, Russler-Germain DA, Frenkel F, Barnell EK, McClain ED, Desai S, Schappe T, Onyeador OC, Kudryashova O, Belousov V, Bagaev A, Ocheredko E, Kiwala S, Hundal J, Skidmore ZL, Watkins MP, Mooney TB, Walker JR, Krysiak K, Gomez F, Fronick CC, Fulton RS, Schreiber RD, Mehta-Shah N, Cashen AF, Kahl BS, Ataullakhanov R, Bartlett NL, Griffith M, Griffith OL, Fehniger TA. Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. Blood Adv. 2024 Aug 13;8(15):4035-4049. doi: 10.1182/bloodadvances.2022007792. © 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Ramirez, Cody A; Becker-Hapak, Michelle; Singhal, Kartik; Russler-Germain, David A; Barnell, Erica K; McClain, Ethan D; Desai, Sweta; Schappe, Timothy; Onyeador, Onyinyechi C; Kiwala, Susanna; Hundal, Jasreet; Skidmore, Zachary L; Watkins, Marcus P; Mooney, Thomas B; Walker, Jason R; Krysiak, Kilannin; Gomez, Felicia; Fronick, Catrina C; Fulton, Robert S; Schreiber, Robert D; Mehta-Shah, Neha; Cashen, Amanda F; Kahl, Brad S; Bartlett, Nancy L; Griffith, Malachi; Griffith, Obi L; Fehniger, Todd A; and et al., "Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma." Blood Advances. 8, 15. 4035 - 4049. (2024).
https://digitalcommons.wustl.edu/oa_4/4110
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
